NVIDIA
NVDA
Tesla
TSLA
Intel
INTC
Disney
DIS
Micron Technology
MU
US Stock MarketDetailed Quotes
TNFA TNF Pharmaceuticals
- 0.418
- -0.012-2.70%
Close Feb 28 16:00 ET
- 0.485
- +0.067+16.00%
Post 19:59 ET
1.15MMarket Cap-0.03P/E (TTM)
0.429High0.410Low1.55MVolume0.417Open0.430Pre Close739.98KTurnover64.80%Turnover RatioLossP/E (Static)2.76MShares3.60052wk High0.07P/B997.46KFloat Cap0.41052wk Low--Dividend TTM2.39MShs Float6469632.000Historical High--Div YieldTTM4.35%Amplitude0.410Historical Low0.478Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
TNF Pharmaceuticals Stock Forum
Can This First-Ever Oral TNF Inhibitor Disrupt a $40 Billion Market? Phase 2b Trial Begins
TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor
Tuesday, 25th February at 9:20 am
Fully funded multi-center study initiated at University of Florida to further explore efficacy of isomyosamine for preventing progressive muscle loss and frailty
Study builds on positive results achieved in earlier Phase 2a trial
TNF-alpha inhibitor market estimated at $40+ billion with no FDA-approved oral treatments
TNF Pharmaceuticals, In...
On watch not sure what's happening right now but like the AH chart. Don't want to get caught in a dump so will be looking at this one closely tomorrow morning.
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press r...
TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment
Wednesday, 29th January at 9:15 am
Series of studies to observe signals of inflammation and TNF-alpha levels in patients taking GLP-1s including Wegovy® or Ozempic®
Lean body mass accounts for up to 40% of weight loss from GLP-1 treatments
Potential entry into high growth GLP-1 market of nearly $50 billion in 2024, projected value of $100 billion...
No comment yet